Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4843769

COc1cccc(CNCCOc2ccc(-c3nc4cc(Br)cnc4[nH]3)cc2)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 1/20 0.42
MMP13 P45452 3/20 0.42
CASR P41180 1/20 0.40
HTR5A P47898 1/20 0.40
SCN8A Q9UQD0 1/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC3 O15379 1/20 0.38
BRD4 O60885 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4834677 0.93 SCN8A (0.44) KMT2AMEN1KDM4EALDH1A1MMP13
Trifluoroacetic Acid SCHEMBL4840737 0.92 HDAC6 (0.44) KDM4EHDAC6HDAC3BRD4HDAC4
Trifluoroacetic Acid SCHEMBL4842803 0.91 KMT2A (0.45) KMT2AMEN1KDM4EHDAC6HDAC3
SCHEMBL6221322 0.90 BCHE (0.43) KMT2AMEN1KDM4EALDH1A1SCN8A
Trifluoroacetic Acid SCHEMBL4837280 0.90 CDK4 (0.40) KMT2AMEN1CASRHDAC6HDAC3
Trifluoroacetic Acid SCHEMBL4846277 0.89 KMT2A (0.42) KMT2AMEN1ALDH1A1MMP13BCHE
Trifluoroacetic Acid SCHEMBL4844163 0.88 HIF1A (0.46) KMT2AMEN1MMP13
Trifluoroacetic Acid SCHEMBL4840541 0.87 HTR5A (0.42) KMT2AKDM4EMMP13HTR5AHDAC6
Trifluoroacetic Acid SCHEMBL4844131 0.86 HDAC6 (0.39) KMT2AALDH1A1HTR5AHDAC6HDAC3
Trifluoroacetic Acid SCHEMBL4837229 0.86 KDM4E (0.40) KMT2AMEN1KDM4EALDH1A1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 KMT2A 2697/4885MEN1 2592/4885KDM4E 2903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.